• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients.

作者信息

Masset Christophe, Benotmane Ilies, Dantal Jacques, Garandeau Claire, Gauthier-Vargas Gabriella, Cantarovich Diego, Meurette Aurélie, Giral Magali, Caillard Sophie, Blancho Gilles

机构信息

Service de Néphrologie et Immunologie Clinique Institut de Transplantation Urologie Néphrologie, Centre Hospitalo-Universitaire Nantes, Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.

Nephrology and Transplantation Department, Centre Hospitalier Universitaire, Strasbourg, France.

出版信息

Kidney Int. 2022 Apr;101(4):825-826. doi: 10.1016/j.kint.2022.01.017. Epub 2022 Feb 12.

DOI:10.1016/j.kint.2022.01.017
PMID:35167873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8839796/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/458c/8839796/d8cffb891c75/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/458c/8839796/d8cffb891c75/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/458c/8839796/d8cffb891c75/gr1_lrg.jpg

相似文献

1
A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients.严格血清阴性肾移植受者中的第四种SARS-CoV-2 mRNA疫苗。
Kidney Int. 2022 Apr;101(4):825-826. doi: 10.1016/j.kint.2022.01.017. Epub 2022 Feb 12.
2
Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.肾移植受者中mRNA-1273和BNT162b2新冠病毒mRNA疫苗免疫原性的比较
Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.
3
The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.SARS-CoV-2 疫苗的种类会影响肾移植受者的血清学反应。
Clin Transplant. 2022 Apr;36(4):e14585. doi: 10.1111/ctr.14585. Epub 2022 Jan 18.
4
Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.肾移植受者在接种第三剂mRNA疫苗后对新冠病毒奥密克戎变异株的抗体反应欠佳。
Kidney Int. 2022 Jun;101(6):1282-1286. doi: 10.1016/j.kint.2022.04.009. Epub 2022 Apr 13.
5
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients.肾移植受者接种第三剂 SARS-CoV-2 疫苗后的体液免疫反应。
Transplant Proc. 2022 Jul-Aug;54(6):1439-1445. doi: 10.1016/j.transproceed.2022.02.011. Epub 2022 Mar 1.
6
Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.青少年实体器官移植受者对三种SARS-CoV-2 mRNA疫苗的抗体反应。
Am J Transplant. 2022 Oct;22(10):2481-2483. doi: 10.1111/ajt.17085. Epub 2022 May 13.
7
Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients.肾移植受者对SARS-CoV-2 mRNA疫苗的抗体反应
Exp Clin Transplant. 2022 Nov;20(11):1048. doi: 10.6002/ect.2022.0176.
8
Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients.在接受mRNA疫苗初免的肾移植受者中，第三剂异源载体疫苗Ad26.COVS1接种后SARS-CoV-2抗体反应增强。
Transpl Int. 2022 Mar 22;36:10357. doi: 10.3389/ti.2022.10357. eCollection 2022.
9
A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients.mRNA-1273新冠病毒疫苗的第四剂增强了肾移植受者血清对德尔塔变异株的中和作用。
Kidney Int. 2022 May;101(5):1073-1076. doi: 10.1016/j.kint.2022.02.011. Epub 2022 Feb 26.
10
Humoral Response After Five Successive Doses of SARS-CoV-2 mRNA Vaccine in Kidney Transplant Patients.肾移植患者连续五剂接种SARS-CoV-2 mRNA疫苗后的体液免疫反应
Transplantation. 2023 Jul 1;107(7):e188-e189. doi: 10.1097/TP.0000000000004628. Epub 2023 May 12.

引用本文的文献

1
Booster effect of the fourth dose of the SARS-CoV-2 mRNA vaccine in kidney transplant recipients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）mRNA疫苗第四剂对肾移植受者的加强作用。
Clin Exp Nephrol. 2025 Mar 11. doi: 10.1007/s10157-025-02651-6.
2
Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial.膳食菊粉改善肾移植受者对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗的反应：RIVASTIM-菊粉随机对照试验
Vaccines (Basel). 2024 Jun 3;12(6):608. doi: 10.3390/vaccines12060608.
3
Immunogenicity and Safety of the Three-Dose COVID-19 Vaccine Regimen in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series.肾移植受者对第四剂信使核糖核酸新冠疫苗的抗体反应：病例系列
Ann Intern Med. 2022 Mar;175(3):455-456. doi: 10.7326/L21-0598. Epub 2022 Jan 11.
2
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.针对有症状和无症状 SARS-CoV-2 感染的保护相关因素。
Nat Med. 2021 Nov;27(11):2032-2040. doi: 10.1038/s41591-021-01540-1. Epub 2021 Sep 29.
3
COVID-19 vaccination in kidney transplant recipients.
接受肾脏替代治疗患者的三剂新冠疫苗接种方案的免疫原性和安全性：一项系统评价和荟萃分析
Kidney Dis (Basel). 2024 Jan 19;10(2):107-117. doi: 10.1159/000536308. eCollection 2024 Apr.
4
Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney Diseases.3剂BNT162b2对肾病患儿的体液免疫原性和细胞免疫原性
Kidney Int Rep. 2023 Aug 28;8(11):2356-2367. doi: 10.1016/j.ekir.2023.08.014. eCollection 2023 Nov.
5
Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.实体器官移植受者对 SARS-CoV-2 感染的易感性和对 COVID-19 疫苗接种的免疫反应。
J Infect Dis. 2023 Aug 4;228(Suppl 1):S34-S45. doi: 10.1093/infdis/jiad152.
6
Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study.荷兰肾移植受者接种SARS-CoV-2疫苗后及知晓抗体反应后的预防措施依从性：一项全国性问卷调查研究
EClinicalMedicine. 2023 Jul 20;62:102103. doi: 10.1016/j.eclinm.2023.102103. eCollection 2023 Aug.
7
A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients.第三剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗可改善慢性肾病患者的免疫反应。
Vaccines (Basel). 2023 May 22;11(5):1012. doi: 10.3390/vaccines11051012.
8
Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System.大型美国医疗体系中免疫功能低下个体对 mRNA COVID-19 疫苗接种情况的分析。
JAMA Netw Open. 2023 Jan 3;6(1):e2251833. doi: 10.1001/jamanetworkopen.2022.51833.
9
Serological response to Nuvaxovid (NVX-CoV2373) vaccine given as a fifth dose in non- and low-responder kidney transplant recipients.在无应答和低应答肾移植受者中作为第五剂接种Nuvaxovid（NVX-CoV2373）疫苗后的血清学反应。
Nephrol Dial Transplant. 2023 May 31;38(6):1564-1566. doi: 10.1093/ndt/gfad010.
10
COVID-19 Vaccination in Kidney Transplant Candidates and Recipients.肾移植候选者和接受者中的新冠病毒疫苗接种
Vaccines (Basel). 2022 Oct 27;10(11):1808. doi: 10.3390/vaccines10111808.
肾移植受者的 COVID-19 疫苗接种。
Nat Rev Nephrol. 2021 Dec;17(12):785-787. doi: 10.1038/s41581-021-00491-7.
4
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.移植受者中第三剂mRNA-1273疫苗的随机试验。
N Engl J Med. 2021 Sep 23;385(13):1244-1246. doi: 10.1056/NEJMc2111462. Epub 2021 Aug 11.
5
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.皮下注射 REGEN-COV 抗体组合以预防 COVID-19。
N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4.
6
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients.成年移植受者中出现SARS-CoV-2突破性感染的风险。
Transplantation. 2021 Nov 1;105(11):e265-e266. doi: 10.1097/TP.0000000000003907.